Valeant Names ValueAct’s Ubben to Board Amid Allergan Battle
Alert: HALISTER Source: BN (Bloomberg News)
Tickers AGN US (Allergan Inc/United States) VRX CN (Valeant Pharmaceuticals International Inc) 0222451Z US (ValueAct Capital Management LLC) 83311Z US (ValueAct Capital Partners LP)
People Jeffrey Ubben (ValueAct Capital Management LLC)
Topics Who's News - People Management Changes
To de-activate this alert, run {NLRT DEACT HALISTER <GO>}. To modify this alert, run {NLRT EDIT HALISTER <GO>}.
UUID: 7947283